Gwynn Douglas Long | Scholars@Duke

Gwynn Douglas Long
Professor of Medicine

1. High dose therapy and autologous and allogeneic stem cell rescue for hematologic malignancies (especially multiple myeloma) and solid tumors.
2. Non-myeloablative allogeneic transplants for hematologic malignancies and solid tumors.
3. Supportive care for hematopoietic stem cell transplants.
4. Prevention and therapy of graft versus host disease.

Current Appointments & Affiliations

Professor of Medicine, Medicine, Hematologic Malignancies and Cellular Therapy, Medicine 2011

Contact Information

2400 Pratt St Ste 1100, Durham, NC 27705
Box 3961 Med Ctr, Durham, NC 27710
gwynn.long@duke.edu (919) 668-1011

Background
Education, Training, & Certifications
- Fellow in Medical Oncology, Medicine, Stanford University 1987 - 1990
- Medical Resident, Medicine, Vanderbilt University 1983 - 1986
- M.D., Wake Forest University 1983
- M.S., Wake Forest University 1979
Duke Appointment History
- Associate Professor of Medicine, Medicine, Hematologic Malignancies and Cellular Therapy, Medicine 2010 - 2011
- Associate Professor of Medicine, Medicine, Hematologic Malignancies and Cellular Therapy, Medicine 2005 - 2010
- Instructor, Temporary in the Department of Medicine, Medicine, Hematologic Malignancies and Cellular Therapy, Medicine 2004 - 2005
- Associate Clinical Professor of Medicine, Medicine, Medical Oncology, Medicine 1998 - 2003
- Instructor, Temporary in the Department of Medicine, Medicine, Medical Oncology, Medicine 1997 - 1998
Research
Selected Grants
- Transfusion Medicine and Hematology awarded by National Institutes of Health 1975 - 2021
- CMX001-301 awarded by Chimerix, Inc. 2013 - 2016
Publications & Artistic Works
Selected Publications
- Conference Papers
  - Anand, S, Thomas, S, Corbet, K, Gasparetto, C, Long, GD, Lopez, R, Morris, AK, Rizzieri, DA, Sullivan, KM, Sung, AD, Sarantopoulos, S, Chao, NJ, and Horwitz, ME. "Adult Umbilical Cord Blood Transplantation Using Myeloablative Thiotepa, Total Body Irradiation, and Fludarabine Conditioning." November 2017. Full Text
  - Horning, SJ, Chao, NJ, Negrin, RS, Hoppe, RT, Kwak, LW, Long, GD, Stallbaum, B, O'Connor, P, and Blume, KG. "The Stanford experience with high-dose etoposide cytoreductive regimens and autologous bone marrow transplantation in Hodgkin's disease and non-Hodgkin's lymphoma: Preliminary data." January 1, 1991.
- Journal Articles
  - Huang, L-W, Bacon, W, Cirrincione, C, Peterson, B, Long, G, Rizzieri, D, Sullivan, KM, Corbet, K, Horwitz, M, Chao, N, Gasparetto, C, and Tuchman, SA. "Efficacy and safety of high-dose chemotherapy with autologous stem cell transplantation in senior versus younger adults with newly diagnosed multiple myeloma." Hematological oncology 35, no. 4 (December 2017): 752-759. Full Text
  - Anand, S, Thomas, S, Hyslop, T, Adcock, J, Corbet, K, Gasparetto, C, Lopez, R, Long, GD, Morris, AK, Rizzieri, DA, Sullivan, KM, Sung, AD, Sarantopoulos, S, Chao, NJ, and Horwitz, ME. "Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 23, no. 7 (July 2017): 1151-1157. Full Text
  - Tuchman, SA, Moore, JO, DeCastro, CD, Li, Z, Sellars, E, Kang, Y, Long, G, and Gasparetto, CG. "Phase II study of dose-attenuated bortezomib, cyclophosphamide and dexamethasone ("VCD-Lite") in very old or otherwise toxicity-vulnerable adults with newly diagnosed multiple myeloma." Journal of geriatric oncology 8, no. 3 (May 2017): 165-169. Full Text
  - Sivaraj, D, Green, MM, Li, Z, Sung, AD, Sarantopoulos, S, Kang, Y, Long, GD, Horwitz, ME, Lopez, RD, Sullivan, KM, Rizzieri, DA, Chao, NJ, and Gasparetto, C. "Outcomes of Maintenance Therapy with Bortezomib after Autologous Stem Cell Transplantation for Patients with Multiple Myeloma." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 23, no. 2 (February 2017): 262-268. Full Text
  - Sung, AD, Sung, JAM, Thomas, S, Hyslop, T, Gasparetto, C, Long, G, Rizzieri, D, Sullivan, KM, Corbet, K, Broadwater, G, Chao, NJ, and Horwitz, ME. "Universal Mask Usage for Reduction of Respiratory Viral Infections After Stem Cell Transplant: A Prospective Trial." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 63, no. 8 (October 2016): 999-1006. Full Text
  - Green, MMB, Chao, N, Chhabra, S, Corbet, K, Gasparetto, C, Horwitz, A, Li, Z, Venkata, JK, Long, G, Mims, A, Rizzieri, D, Sarantopoulos, S, Stuart, R, Sung, AD, Sullivan, KM, Costa, L, Horwitz, M, and Kang, Y. "Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery." Journal of hematology & oncology 9, no. 1 (August 17, 2016): 71-. Full Text Open Access Copy
  - Tuchman, SA, Bacon, WA, Huang, L-W, Long, G, Rizzieri, D, Horwitz, M, Chute, JP, Sullivan, K, Morris Engemann, A, Yopp, A, Li, Z, Corbet, K, Chao, N, and Gasparetto, C. "Cyclophosphamide-based hematopoietic stem cell mobilization before autologous stem cell transplantation in newly diagnosed multiple myeloma." Journal of clinical apheresis 30, no. 3 (June 2015): 176-182. Full Text
  - Long, G, Waller, EK, Gregurek, S, Tricot, G, Marschner, S, and Bill, J. "Evaluation of the spectra Optia® mononuclear cell collection procedure in multiple myeloma patients." Journal of clinical apheresis 30, no. 1 (February 2015): 1-7. Full Text
  - Tuchman, SA, Lane, A, Hornsby, WE, Bishop, C, Thomas, S, Herndon, JE, Long, G, Gasparetto, C, and Jones, LW. "Quantitative measures of physical functioning after autologous hematopoietic stem cell transplantation in multiple myeloma: a feasibility study." Clinical lymphoma, myeloma & leukemia 15, no. 2 (February 2015): 103-109. Full Text
  - Long, G, Waller, EK, Gregurek, S, Tricot, G, Marschner, S, and Bill, J. "Evaluation of the Spectra Optia® mononuclear cell collection procedure in multiple myeloma patients." Journal of Clinical Apheresis 30, no. 1 (2015): 1-7. Full Text
  - Tuchman, SA, Bacon, WA, Huang, LW, Long, G, Rizzieri, D, Horwitz, M, Chute, JP, Sullivan, K, Engemann, AM, Yopp, A, Li, Z, Corbet, K, Chao, N, and Gasparetto, C. "Cyclophosphamide-based hematopoietic stem cell mobilization before autologous stem cell transplantation in newly diagnosed multiple myeloma." Journal of Clinical Apheresis 30, no. 3 (January 1, 2015): 176-182. Full Text
  - Horwitz, ME, Chao, NJ, Rizzieri, DA, Long, GD, Sullivan, KM, Gasparetto, C, Chute, JP, Morris, A, McDonald, C, Waters-Pick, B, Stiff, P, Wease, S, Peled, A, Snyder, D, Cohen, EG, Shoham, H, Landau, E, Friend, E, Peleg, I, Aschengrau, D, Yackoubov, D, Kurtzberg, J, and Peled, T. "Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment." The Journal of clinical investigation 124, no. 7 (July 2014): 3121-3128. Full Text
  - Kanda, J, Long, GD, Gasparetto, C, Horwitz, ME, Sullivan, KM, Chute, JP, Morris, A, Shafique, M, Li, Z, Chao, NJ, and Rizzieri, DA. "Reduced-intensity allogeneic transplantation using alemtuzumab from HLA-matched related, unrelated, or haploidentical related donors for patients with hematologic malignancies." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20, no. 2 (February 2014): 257-263. Full Text
  - Kanda, J, Kaynar, L, Kanda, Y, Prasad, VK, Parikh, SH, Lan, L, Shen, T, Rizzieri, DA, Long, GD, Sullivan, KM, Gasparetto, C, Chute, JP, Morris, A, Winkel, S, McPherson, J, Kurtzberg, J, Chao, NJ, and Horwitz, ME. "Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment." Bone Marrow Transplant 48, no. 7 (July 2013): 926-931. Full Text Link to Item
  - Held, LA, Rizzieri, D, Long, GD, Gockerman, JP, Diehl, LF, de Castro, CM, Moore, JO, Horwitz, ME, Chao, NJ, and Gasparetto, C. "A Phase I study of arsenic trioxide (Trisenox), ascorbic acid, and bortezomib (Velcade) combination therapy in patients with relapsed/refractory multiple myeloma." Cancer Invest 31, no. 3 (March 2013): 172-176. Full Text Link to Item
  - Kanda, J, Kaynar, L, Kanda, Y, Prasad, VK, Parikh, SH, Lan, L, Shen, T, Rizzieri, DA, Long, GD, Sullivan, KM, Gasparetto, C, Chute, JP, Morris, A, Winkel, S, McPherson, J, Kurtzberg, J, Chao, NJ, and Horwitz, ME. "Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: Risk factors and response to treatment." Bone Marrow Transplantation 48, no. 7 (2013): 926-931. Full Text
  - Kanda, J, Chiou, L-W, Szabolcs, P, Sempowski, GD, Rizzieri, DA, Long, GD, Sullivan, KM, Gasparetto, C, Chute, JP, Morris, A, McPherson, J, Hale, J, Livingston, JA, Broadwater, G, Niedzwiecki, D, Chao, NJ, and Horwitz, ME. "Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation." Biol Blood Marrow Transplant 18, no. 11 (November 2012): 1664-1676.e1. Full Text Link to Item
  - Spasojevic, I, da Costa, LRS, Horwitz, ME, Long, GD, Sullivan, KM, Chute, JP, Gasparetto, C, Morris, A, Chao, NJ, and Rizzieri, DA. "Mini test dose of intravenous busulfan (busulfex(®)) in allogeneic non-myeloablative stem cell transplantation, followed by liquid chromatography tandem-mass spectrometry." Cancer Invest 30, no. 9 (November 2012): 679-682. Full Text Link to Item
  - Horwitz, ME, Long, G, Holman, P, Libby, E, Calandra, GC, and Schriber, JR. "Efficacy and safety of hematopoietic stem cell remobilization with plerixafor+G-CSF in adult patients with germ cell tumors." Bone Marrow Transplant 47, no. 10 (October 2012): 1283-1286. Full Text Link to Item
  - Horwitz, ME, Chute, JP, Gasparetto, C, Long, GD, McDonald, C, Morris, A, Rizzieri, DA, Sullivan, KM, and Chao, NJ. "Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration." Bone Marrow Transplant 47, no. 8 (August 2012): 1051-1055. Full Text Link to Item
  - Chen, D-F, Prasad, VK, Broadwater, G, Reinsmoen, NL, DeOliveira, A, Clark, A, Sullivan, KM, Chute, JP, Horwitz, ME, Gasparetto, C, Long, GD, Yang, Y, Chao, NJ, and Rizzieri, DA. "Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors." Bone Marrow Transplant 47, no. 6 (June 2012): 817-823. Full Text Link to Item
  - Kanda, J, Horwitz, ME, Long, GD, Gasparetto, C, Sullivan, KM, Chute, JP, Morris, A, Hennig, T, Li, Z, Chao, NJ, and Rizzieri, DA. "Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation." Bone Marrow Transplant 47, no. 5 (May 2012): 700-705. Full Text Link to Item
  - Jagasia, MH, Abonour, R, Long, GD, Bolwell, BJ, Laport, GG, Shore, TB, Durrant, S, Szer, J, Chen, M-G, Lizambri, R, and Waller, EK. "Palifermin for the reduction of acute GVHD: A randomized, double-blind, placebo-controlled trial." Bone Marrow Transplantation 47, no. 10 (2012): 1350-1355. Full Text
  - Kanda, J, Rizzieri, DA, Gasparetto, C, Long, GD, Chute, JP, Sullivan, KM, Morris, A, Smith, CA, Hogge, DE, Nitta, J, Song, K, Niedzwiecki, D, Chao, NJ, and Horwitz, ME. "Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning." Biol Blood Marrow Transplant 17, no. 6 (June 2011): 867-874. Full Text Link to Item
  - Craciunescu, OI, Steffey, BA, Kelsey, CR, Larrier, NA, Paarz-Largay, CJ, Prosnitz, RG, Chao, N, Chute, J, Gasparetto, C, Horwitz, M, Long, G, Rizzieri, D, and Sullivan, KM. "Renal shielding and dosimetry for patients with severe systemic sclerosis receiving immunoablation with total body irradiation in the scleroderma: cyclophosphamide or transplantation trial." Int J Radiat Oncol Biol Phys 79, no. 4 (March 15, 2011): 1248-1255. Full Text Link to Item
  - Rizzieri, DA, Crout, C, Storms, R, Golob, J, Long, GD, Gasparetto, C, Sullivan, KM, Horwitz, M, Chute, J, Lagoo, AS, Morris, A, Beaven, A, Yang, Y, Peterson, B, Li, Z, and Chao, NJ. "Feasibility of low-dose interleukin-2 therapy following T-cell-depleted nonmyeloablative allogeneic hematopoietic stem cell transplantation from HLA-matched or -mismatched family member donors." Cancer Invest 29, no. 1 (January 2011): 56-61. Full Text Link to Item
  - Rizzieri, DA, Storms, R, Chen, D-F, Long, G, Yang, Y, Nikcevich, DA, Gasparetto, C, Horwitz, M, Chute, J, Sullivan, K, Hennig, T, Misra, D, Apple, C, Baker, M, Morris, A, Green, PG, Hasselblad, V, and Chao, NJ. "Natural killer cell-enriched donor lymphocyte infusions from A 3-6/6 HLA matched family member following nonmyeloablative allogeneic stem cell transplantation." Biol Blood Marrow Transplant 16, no. 8 (August 2010): 1107-1114. Full Text Link to Item
  - Crout, CA, Koh, L-P, Gockerman, JP, Moore, JO, Decastro, C, Long, GD, Diehl, L, Gasparetto, C, Niedzwiecki, D, Edwards, J, Prosnitz, L, Horwitz, M, Chute, J, Morris, A, Davis, P, Beaven, A, Chao, NJ, Ali-Osman, F, and Rizzieri, DA. "Overcoming drug resistance in mantle cell lymphoma using a combination of dose-dense and intense therapy." Cancer Invest 28, no. 6 (July 2010): 654-660. Full Text Link to Item
  - Gasparetto, C, Gockerman, JP, Diehl, LF, de Castro, CM, Moore, JO, Long, GD, Horwitz, ME, Keogh, G, Chute, JP, Sullivan, KM, Neuwirth, R, Davis, PH, Sutton, LM, Anderson, RD, Chao, NJ, and Rizzieri, D. ""Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma." Biol Blood Marrow Transplant 16, no. 1 (January 2010): 70-77. Full Text Link to Item
  - Rizzieri, DA, Dev, P, Long, GD, Gasparetto, C, Sullivan, KM, Horwitz, M, Chute, J, and Chao, NJ. "Response and toxicity of donor lymphocyte infusions following T-cell depleted non-myeloablative allogeneic hematopoietic SCT from 3-6/6 HLA matched donors." Bone Marrow Transplant 43, no. 4 (February 2009): 327-333. Full Text Link to Item
  - Horwitz, ME, Morris, A, Gasparetto, C, Sullivan, K, Long, G, Chute, J, Rizzieri, D, McPherson, J, and Chao, N. "Myeloablative intravenous busulfan/fludarabine conditioning does not facilitate reliable engraftment of dual umbilical cord blood grafts in adult recipients." Biol Blood Marrow Transplant 14, no. 5 (May 2008): 591-594. Full Text Link to Item
  - Byrne, BJ, Horwitz, M, Long, GD, Gasparetto, C, Sullivan, KM, Chute, J, Chao, NJ, and Rizzieri, DA. "Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection." Bone Marrow Transplant 41, no. 1 (January 2008): 39-43. Full Text Link to Item
  - Horwitz, ME, Spasojevic, I, Morris, A, Telen, M, Essell, J, Gasparetto, C, Sullivan, K, Long, G, Chute, J, Chao, N, and Rizzieri, D. "Fludarabine-based nonmyeloablative stem cell transplantation for sickle cell disease with and without renal failure: clinical outcome and pharmacokinetics." Biol Blood Marrow Transplant 13, no. 12 (December 2007): 1422-1426. Full Text Link to Item
  - Hanson, KE, Reller, LB, Kurtzberg, J, Horwitz, M, Long, G, and Alexander, BD. "Comparison of the Digene Hybrid Capture System Cytomegalovirus (CMV) DNA (version 2.0), Roche CMV UL54 analyte-specific reagent, and QIAGEN RealArt CMV LightCycler PCR reagent tests using AcroMetrix OptiQuant CMV DNA quantification panels and specimens from allogeneic-stem-cell transplant recipients." J Clin Microbiol 45, no. 6 (June 2007): 1972-1973. Full Text Link to Item
  - Rizzieri, DA, Koh, LP, Long, GD, Gasparetto, C, Sullivan, KM, Horwitz, M, Chute, J, Smith, C, Gong, JZ, Lagoo, A, Niedzwiecki, D, Dowell, JM, Waters-Pick, B, Liu, C, Marshall, D, Vredenburgh, JJ, Gockerman, J, Decastro, C, Moore, J, and Chao, NJ. "Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution." J Clin Oncol 25, no. 6 (February 20, 2007): 690-697. Full Text Link to Item
  - Lagoo, AS, Gong, JZ, Stenzel, TT, Goodman, BK, Buckley, PJ, Chao, NJ, Gasparetto, C, Long, GD, and Rizzieri, DA. "Morphologic examination of sequential bone marrow biopsies after nonmyeloablative stem cell transplantation complements molecular studies of donor engraftment." Arch Pathol Lab Med 130, no. 10 (October 2006): 1479-1488. Full Text Link to Item
  - Alexander, BD, Schell, WA, Miller, JL, Long, GD, and Perfect, JR. "Candida glabrata fungemia in transplant patients receiving voriconazole after fluconazole." Transplantation 80, no. 6 (September 27, 2005): 868-871. Link to Item
  - Chao, NJ, Koh, L-P, Long, GD, Gasparetto, C, Horwitz, M, Morris, A, Lassiter, M, Sullivan, KM, and Rizzieri, DA. "Adult recipients of umbilical cord blood transplants after nonmyeloablative preparative regimens." Biol Blood Marrow Transplant 10, no. 8 (August 2004): 569-575. Full Text Link to Item
  - Rizzieri, DA, Sand, GJ, McGaughey, D, Moore, JO, DeCastro, C, Chao, NJ, Vredenburgh, JJ, Gasparetto, C, Long, GD, Anderson, E, Foster, T, Toaso, B, Adams, D, Niedzwiecki, D, and Gockerman, JP. "Low-dose weekly paclitaxel for recurrent or refractory aggressive non-Hodgkin lymphoma." Cancer 100, no. 11 (June 1, 2004): 2408-2414. Full Text Link to Item
  - Long, GD, Laughlin, M, Madan, B, Kurtzberg, J, Gasparetto, C, Morris, A, Rizzieri, D, Smith, C, Vredenburgh, J, Halperin, EC, Broadwater, G, Niedzwiecki, D, and Chao, NJ. "Unrelated umbilical cord blood transplantation in adult patients." Biol Blood Marrow Transplant 9, no. 12 (December 2003): 772-780. Full Text Link to Item
  - Rizzieri, DA, Talbot, JT, Long, GD, Vredenburgh, JJ, Gasparetto, C, Smith, CS, Colvin, MO, Adams, D, Morris, A, Dodge, R, Loftis, J, Waters-Pick, B, Reese, M, Carawan, H, Koh, LP, and Chao, NJ. "4-hydroperoxycyclophosphamide--purged peripheral blood stem cells for autologous transplantation in patients with acute myeloid leukemia." Biol Blood Marrow Transplant 9, no. 3 (March 2003): 183-188. Full Text Link to Item
  - Rizzieri, DA, Ibom, VK, Moore, JO, DeCastro, CM, Rosner, GL, Adams, DJ, Foster, T, Payne, N, Thompson, M, Vredenburgh, JJ, Gasparetto, C, Long, GD, Chao, NJ, and Gockerman, JP. "Phase I evaluation of prolonged-infusion gemcitabine with fludarabine for relapsed or refractory acute myelogenous leukemia." Clin Cancer Res 9, no. 2 (February 2003): 663-668. Link to Item
  - McCune, SL, Gockerman, JP, Moore, JO, Decastro, CM, Bass, AJ, Chao, NJ, Long, GD, Vredenburgh, JJ, Gasparetto, C, Adams, D, Payne, N, and Rizzieri, DA. "Alemtuzumab in relapsed or refractory chronic lymphocytic leukemia and prolymphocytic leukemia." Leuk Lymphoma 43, no. 5 (May 2002): 1007-1011. Full Text Link to Item
  - Gasparetto, C, Gasparetto, M, Morse, M, Rooney, B, Vredenburgh, JJ, Long, GD, Rizzieri, DA, Loftis, J, Chao, NJ, and Smith, C. "Mobilization of dendritic cells from patients with breast cancer into peripheral blood stem cell leukapheresis samples using Flt-3-Ligand and G-CSF or GM-CSF." Cytokine 18, no. 1 (April 7, 2002): 8-19. Link to Item
  - Chao, NJ, Liu, CX, Rooney, B, Chen, BJ, Long, GD, Vredenburgh, JJ, Morris, A, Gasparetto, C, and Rizzieri, DA. "Nonmyeloablative regimen preserves "niches" allowing for peripheral expansion of donor T-cells." Biol Blood Marrow Transplant 8, no. 5 (2002): 249-256. Link to Item
  - Garantziotis, S, Bhalla, KS, Long, GD, Vredenburgh, JJ, and Folz, RJ. "Fatal re-expansion pulmonary edema associated with increased lung IL-8 levels following high-dose chemotherapy and autologous stem cell transplant." Respiration 69, no. 4 (2002): 351-354. Full Text Link to Item
  - Stuart, MJ, Peters, WP, Broadwater, G, Hussein, A, Ross, M, Marks, LB, Folz, RJ, Long, GD, Rizzieri, D, Chao, NJ, and Vredenburgh, JJ. "High-dose chemotherapy and hematopoietic support for patients with high-risk primary breast cancer and involvement of 4 to 9 lymph nodes." Biology of Blood and Marrow Transplantation 8, no. 12 (2002): 666-673. Full Text
  - Rizzieri, DA, Long, GD, Vredenburgh, JJ, Gasparetto, C, Morris, A, Stenzel, TT, Davis, P, and Chao, NJ. "Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen." Blood 98, no. 12 (December 1, 2001): 3486-3488. Link to Item
  - Bhagat, R, Sporn, TA, Long, GD, and Folz, RJ. "Amiodarone and cyclophosphamide: potential for enhanced lung toxicity." Bone Marrow Transplant 27, no. 10 (May 2001): 1109-1111. Full Text Link to Item
  - Horning, SJ, Negrin, RS, Hoppe, RT, Rosenberg, SA, Chao, NJ, Long, GD, Brown, BW, and Blume, KG. "High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial." Blood 97, no. 2 (January 15, 2001): 404-409. Link to Item
  - Deeg, HJ, Blazar, BR, Bolwell, BJ, Long, GD, Schuening, F, Cunningham, J, Rifkin, RM, Abhyankar, S, Briggs, AD, Burt, R, Lipani, J, Roskos, LK, White, JM, Havrilla, N, Schwab, G, and Heslop, HE. "Treatment of steroid-refractory acute graft-versus-host disease with anti-CD147 monoclonal antibody ABX-CBL." Blood 98, no. 7 (2001): 2052-2058. Full Text
  - Maddox, L, Long, GD, Vredenburgh, JJ, and Folz, RJ. "Rhizopus presenting as an endobronchial obstruction following bone marrow transplant [3]." Bone Marrow Transplantation 28, no. 6 (2001): 634-636. Full Text
  - McGaughey, DS, Nikcevich, DA, Long, GD, Vredenburgh, JJ, Rizzieri, D, Smith, CA, Broadwater, G, Loftis, JS, McDonald, C, Morris, AK, Folz, RF, and Chao, NF. "Inhaled steroids as prophylaxis for delayed pulmonary toxicity syndrome in breast cancer patients undergoing high-dose chemotherapy and autologous stem cell transplantation." Biol Blood Marrow Transplant 7, no. 5 (2001): 274-278. Link to Item
  - Stuart, MJ, Chao, NS, Horning, SJ, Wong, RM, Negrin, RS, Johnston, LJ, Shizuru, JA, Long, GD, Blume, KG, and Stockerl-Goldstein, KE. "Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease." Biology of Blood and Marrow Transplantation 7, no. 10 (2001): 552-560.
  - Alvarnas, JC, Negrin, RS, Horning, SJ, Hu, WW, Long, GD, Schriber, JR, Stockerl-Goldstein, K, Tierney, K, Wong, R, Blume, KG, and Chao, NJ. "High-Dose Therapy with Hematopoietic Cell Transplantation for Patients with Central Nervous System Involvement by Non-Hodgkin's Lymphoma." Biology of Blood and Marrow Transplantation 6, no. 3 A (2000): 352-358.
  - Chao, NJ, Snyder, DS, Jain, M, Wong, RM, Niland, JC, Negrin, RS, Long, GD, Hu, WW, Stockerl-Goldstein, KE, Johnston, LJ, Amylon, MD, Tierney, DK, O'Donnell, MR, Nademanee, AP, Parker, P, Stein, A, Molina, A, Fung, H, Kashyap, A, Kohler, S, Spielberger, R, Krishnan, A, Rodriguez, R, Forman, SJ, and Bluzme, KG. "Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: results of a prospective double-blind randomized trial." Biol Blood Marrow Transplant 6, no. 3 (2000): 254-261. Link to Item
  - Hu, WW, Negrin, RS, Stockerl-Goldstein, K, Johnston, LJ, Shizuru, JA, Wong, RM, Chao, NJ, Long, GD, Feiner, RH, and Blume, KG. "Four-cycle high-dose therapy with hematopoietic support for metastatic breast cancer: no improvement in outcomes compared with single-course high-dose therapy." Biol Blood Marrow Transplant 6, no. 1 (2000): 58-69. Link to Item
  - Stockerl-Goldstein, KE, Reddy, SA, Horning, SJ, Blume, KG, Chao, NJ, Hu, WW, Johnston, LJ, Long, GD, Strober, S, Wong, RM, Feiner, RH, Kohler, S, and Negrin, RS. "Favorable Treatment Outcome in Non-Hodgkin's Lymphoma Patients with "Poor" Mobilization of Peripheral Blood Progenitor Cells." Biology of Blood and Marrow Transplantation 6, no. 5 (2000): 506-512.
  - Hu, WW, Long, GD, Stockerl-Goldstein, KE, Johnston, LJ, Chao, NJ, Negrin, RS, and Blume, KG. "A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer." Clin Cancer Res 5, no. 11 (November 1999): 3411-3418. Link to Item
  - Rizzieri, DA, Vredenburgh, JJ, Jones, R, Ross, M, Shpall, EJ, Hussein, A, Broadwater, G, Berry, D, Petros, WP, Gilbert, C, Affronti, ML, Coniglio, D, Rubin, P, Elkordy, M, Long, GD, Chao, NJ, and Peters, WP. "Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support." J Clin Oncol 17, no. 10 (October 1999): 3064-3074. Full Text Link to Item
  - Ross, M, Schmidt, GM, Niland, JC, Amylon, MD, Dagis, AC, Long, GD, Nademanee, AP, Negrin, RS, O'Donnell, MR, Parker, PM, Smith, EP, Snyder, DS, Stein, AS, Wong, RM, Forman, SJ, Blume, KG, and Chao, NJ. "Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival." Biol Blood Marrow Transplant 5, no. 5 (1999): 285-291. Link to Item
  - Shpall, EJ, Wheeler, CA, Turner, SA, Yanovich, S, Brown, RA, Pecora, AL, Shea, TC, Mangan, KF, Williams, SF, LeMaistre, CF, Long, GD, Jones, R, Davis, MW, Murphy-Filkins, R, Parker, WRL, and Glaspy, JA. "A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and Filgrastim in high-risk breast cancer patients." Blood 93, no. 8 (1999): 2491-2501.
  - Long, GD, Amylon, MD, Stockerl-Goldstein, KE, Negrin, RS, Chao, NJ, Hu, WW, Nademanee, AP, Snyder, DS, Hoppe, RT, Vora, N, Wong, R, Niland, J, Reichardt, VL, Forman, SJ, and Blume, KG. "Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies." Biol Blood Marrow Transplant 3, no. 6 (December 1997): 324-330. Link to Item
  - Horning, SJ, Chao, NJ, Negrin, RS, Hoppe, RT, Long, GD, Hu, WW, Wong, RM, Brown, BW, and Blume, KG. "High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices." Blood 89, no. 3 (February 1, 1997): 801-813. Link to Item
  - Hausdorff, J, Davis, E, Long, G, Hoppe, R, Pas, MVD, Lassman, C, Kamel, O, and Jacobs, C. "Non-hodgkin's lymphoma of the paranasal sinuses: Clinical and pathological features, and response to combined-modality therapy." Cancer Journal from Scientific American 3, no. 5 (1997): 303-311.
  - Kusnierz-Glaz, CR, Schlegel, PG, Wong, RM, Schriber, JR, Chao, NJ, Amylon, MD, Hu, WW, Negrin, RS, Lee, Y, Blume, KG, and Long, GD. "Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies." J Clin Oncol 15, no. 1 (January 1997): 18-25. Full Text Link to Item
  - Long, GD. "Renal cell carcinoma." Current Opinion in Oncology 9, no. 3 (1997): 301-306.
  - Long, GD, Chao, NJ, Hu, WW, Negrin, RS, Wong, RM, and Blume, KG. "High dose etoposide-based myeloablative therapy followed by autologous blood progenitor cell rescue in the treatment of multiple myeloma." Cancer 78, no. 12 (December 15, 1996): 2502-2509. Link to Item
  - Chao, NJ, Parker, PM, Niland, JC, Wong, RM, Dagis, A, Long, GD, Nademanee, AP, Negrin, RS, Snyder, DS, Hu, WW, Gould, KA, Tierney, DK, Zwingenberger, K, Forman, SJ, and Blume, KG. "Paradoxical effect of thalidomide prophylaxis on chronic graft-vs.-host disease." Biol Blood Marrow Transplant 2, no. 2 (May 1996): 86-92. Link to Item
  - Stockerl-Goldstein, KE, Horning, SJ, Negrin, RS, Chao, NJ, Hu, WW, Long, GD, Hoppe, RT, Amylon, MD, Brown, BW, Wong, RM, and Blume, KG. "Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin's lymphoma." Biol Blood Marrow Transplant 2, no. 2 (May 1996): 76-85. Link to Item
  - Long, GD, Negrin, RS, Hoyle, CF, Kusnierz-Glaz, CR, Schriber, JR, Blume, KG, and Chao, NJ. "Multiple cycles of high dose chemotherapy supported by hematopoietic progenitor cells as treatment for patients with advanced malignancies." Cancer 76, no. 5 (September 1, 1995): 860-868. Link to Item
  - Negrin, RS, Kusnierz-Glaz, CR, Still, BJ, Schriber, JR, Chao, NJ, Long, GD, Hoyle, C, Hu, WW, Horning, SJ, and Brown, BW. "Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma." Blood 85, no. 11 (June 1, 1995): 3334-3341. Link to Item
  - Chao, NJ, Kastrissios, H, Long, GD, Negrin, RS, Horning, SJ, Wong, RM, Blaschke, TF, and Blume, KG. "A new preparatory regimen for autologous bone marrow transplantation for patients with lymphoma." Cancer 75, no. 6 (March 15, 1995): 1354-1359. Link to Item
  - Burns, JM, Tierney, DK, Long, GD, Lambert, SC, and Carr, BE. "Critical pathway for administering high-dose chemotherapy followed by peripheral blood stem cell rescue in the outpatient setting." Oncology nursing forum 22, no. 8 (1995): 1219-1224.
  - O'Donnell, MR, Long, GD, Parker, PM, Niland, J, Nademanee, A, Amylon, M, Chao, N, Negrin, RS, Schmidt, GM, Slovak, ML, Smith, EP, Snyder, DS, Stein, AS, Traweek, T, Blume, KG, and Forman, SJ. "Busulfan/cyclophosphamide as conditioning regimen for allogeneic bone marrow transplantation for myelodysplasia." Journal of Clinical Oncology 13, no. 12 (1995): 2973-2979.
  - Parker, PM, Chao, N, Nademanee, A, O'Donnell, MR, Schmidt, GM, Snyder, DS, Stein, AS, Smith, EP, Molina, A, Stepan, DE, Kashyap, A, Planas, I, Spielberger, R, Somlo, G, Margolin, K, Zwingenberger, K, Wilsman, K, Negrin, RS, and Long, GD. "Thalidomide as salvage therapy for chronic graft-versus-host disease." Blood 86, no. 9 (1995): 3604-3609.
  - Peters, WP, Fay, JW, Holland, HK, Ahmed, T, Bolwell, BJ, Wolf, J, Damon, L, Long, G, Schwartzberg, LS, Goldberg, SL, Friedman, DJ, Lynch, JP, Weinberger, BB, Taylor, RF, Stadtmauer, E, Rifkin, RM, Broun, ER, McCarthy, PL, and Zamkoff, K. "Autologous bone marrow transplantation in primary breast cancer: The American experience." Bone Marrow Transplantation 15, no. SUPPL. 1 (1995): S254-S259.
  - Schriber, JR, Chao, NJ, Long, GD, Negrin, RS, Tierney, DK, Kusnierz-Glaz, C, Lucas, KS, and Blume, KG. "Granulocyte colony-stimulating factor after allogeneic bone marrow transplantation." Blood 84, no. 5 (September 1, 1994): 1680-1684. Link to Item
  - Snyder, DS, Negrin, RS, O'Donnell, MR, Chao, NJ, Amylon, MD, Long, GD, Nademanee, AP, Stein, AS, Parker, PM, Smith, EP, Somlo, G, Margolin, K, Molina, A, Stepan, DE, Lipsett, JA, Hoppe, RT, Slovak, ML, Niland, JC, Dagis, AC, Wong, RM, Forman, SJ, and Blume, KG. "Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase." Blood 84, no. 5 (September 1, 1994): 1672-1679.
  - Snyder, DS, Negrin, RS, O'Donnell, MR, Chao, NJ, Amylon, MD, Long, GD, Nademanee, AP, Stein, AS, Parker, PM, and Smith, EP. "Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase." Blood 84, no. 5 (September 1, 1994): 1672-1679. Link to Item
  - Chao, NJ, Schriber, JR, Long, GD, Negrin, RS, Catolico, M, Brown, BW, Miller, LL, and Blume, KG. "A randomized study of erythropoietin and granulocyte colony-stimulating factor (G-CSF) versus placebo and G-CSF for patients with Hodgkin's and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation." Blood 83, no. 10 (May 15, 1994): 2823-2828. Link to Item
  - Blume, KG, Long, GD, Negrin, RS, Chao, NJ, Kusnierz-Glaz, C, and Amylon, MD. "Role of etoposide (VP-16) in preparatory regimens for patients with leukemia or lymphoma undergoing allogeneic bone marrow transplantation." Bone Marrow Transplant 14 Suppl 4 (1994): S9-10. (Review) Link to Item
  - Horning, SJ, Negrin, RS, Chao, NJ, Long, GD, Hoppe, RT, and Blume, KG. "Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma." Journal of Clinical Oncology 12, no. 12 (1994): 2552-2558.
  - Snyder, DS, Chao, NJ, Amylon, MD, Taguchi, J, Long, GD, Negrin, RS, Nademanee, AP, O'Donnell, MR, Schmidt, GM, and Stein, AS. "Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission." Blood 82, no. 9 (November 1, 1993): 2920-2928. Link to Item
  - Chao, NJ, Schmidt, GM, Niland, JC, Amylon, MD, Dagis, AC, Long, GD, Nademanee, AP, Negrin, RS, O'Donnell, MR, and Parker, PM. "Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease." N Engl J Med 329, no. 17 (October 21, 1993): 1225-1230. Full Text Link to Item
  - Schriber, JR, Negrin, RS, Chao, NJ, Long, GD, Horning, SJ, and Blume, KG. "The efficacy of granulocyte colony-stimulating factor following autologous bone marrow transplantation for non-Hodgkin's lymphoma with monoclonal antibody purged bone marrow." Leukemia 7, no. 10 (October 1993): 1491-1495. Link to Item
  - Chao, NJ, Schriber, JR, Grimes, K, Long, GD, Negrin, RS, Raimondi, CM, Horning, SJ, Brown, SL, Miller, L, and Blume, KG. "Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy." Blood 81, no. 8 (April 15, 1993): 2031-2035. Link to Item
  - Chao, NJ, Stein, AS, Long, GD, Negrin, RS, Amylon, MD, Wong, RM, Forman, SJ, and Blume, KG. "Busulfan/etoposide--initial experience with a new preparatory regimen for autologous bone marrow transplantation in patients with acute nonlymphoblastic leukemia." Blood 81, no. 2 (January 15, 1993): 319-323. Link to Item
  - Chao, NJ, Tierney, DK, Bloom, JR, Long, GD, Barr, TA, Stallbaum, BA, Wong, RM, Negrin, RS, Horning, SJ, and Blume, KG. "Dynamic assessment of quality of life after autologous bone marrow transplantation." Blood 80, no. 3 (August 1, 1992): 825-830. Link to Item
  - Chao, NJ, Long, GD, Negrin, RS, Schriber, JR, Raimondi, CM, Brown, SL, and Blume, KG. "G-CSF and peripheral blood progenitor cells." Lancet 339, no. 8806 (June 6, 1992): 1410-. (Letter) Link to Item
  - Lazarus, HM, Goodnough, LT, Goldwasser, E, Long, G, Arnold, JL, and Strohl, KP. "Serum erythropoietin levels and blood component therapy after autologous bone marrow transplantation: Implications for erythropoietin therapy in this setting." Bone Marrow Transplantation 10, no. 1 (1992): 71-75.
  - Chao, NJ, Nademanee, AP, Long, GD, Schmidt, GM, Donlon, TA, Parker, P, Slovak, ML, Nagasawa, LS, Blume, KG, and Forman, SJ. "Importance of bone marrow cytogenetic evaluation before autologous bone marrow transplantation for Hodgkin's disease." J Clin Oncol 9, no. 9 (September 1991): 1575-1579. Full Text Link to Item
  - Chao, NJ, Duncan, SR, Long, GD, Horning, SJ, and Blume, KG. "Corticosteroid therapy for diffuse alveolar hemorrhage in autologous bone marrow transplant recipients." Ann Intern Med 114, no. 2 (January 15, 1991): 145-146. Link to Item
  - Horning, SJ, Chao, NJ, Negrin, RS, Hoppe, RT, Kwak, LW, Long, GD, Stallbaum, B, O'Connor, P, and Blume, KG. "The Stanford experience with high-dose etoposide cytoreductive regimens and autologous bone marrow transplantation in Hodgkin's disease and non-Hodgkin's lymphoma: preliminary data." Ann Oncol 2 Suppl 1 (January 1991): 47-50. Link to Item
  - Chao, NJ, Amylon, MD, Long, GD, Negrin, RS, Hoppe, RT, Horning, SJ, and Blume, KG. "Bone marrow transplantation for hematologic malignancies: the Stanford experience." Clin Transpl (1990): 157-163. Link to Item
  - DeChatelet, LR, Long, GD, Shirley, PS, Bass, DA, Thomas, MJ, Henderson, FW, and Cohen, MS. "Mechanism of the luminol-dependent chemiluminescence of human neutrophils." Journal of Immunology 129, no. 4 (1982): 1589-1593.
  - Long, GD, DeChatelet, LR, and Thomas, MJ. "Mechanism of luminol enhancement of neutrophil chemiluminescence (CL)." Clinical Research 30, no. 2 (1982): 322A-.
  - Long, GD, DeChatelet, LR, O'Flaherty, JT, McCall, CE, Bass, DA, Shirley, PS, and Parce, JW. "Effects of quercetin on magnesium-dependent adenosine triphosphatase and the metabolism of human polymorphonuclear leukocytes." Blood 57, no. 3 (1981): 561-566.
  - Long, G, DeChatelet, LR, McCall, CE, Bass, DA, and Cooper, MR. "Distinction between alkaline phosphatase and Mg²⁺-ATPase of the human polymorphonuclear leukocyte." Biochemical medicine 22, no. 1 (1979): 88-97.

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Duke Appointment History

Selected Grants

Selected Publications

Conference Papers

Journal Articles